These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 19538859)

  • 1. [Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].
    Han DL; Jiang WR; Yu JM
    Zhonghua Zhong Liu Za Zhi; 2009 Jan; 31(1):1-4. PubMed ID: 19538859
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Basu S; Rao R
    J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
    [No Abstract]   [Full Text] [Related]  

  • 3. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3'-deoxy-3'-18F-fluorothymidine and 18F-FDG.
    Tian J; Yang X; Yu L; Chen P; Xin J; Ma L; Feng H; Tan Y; Zhao Z; Wu W
    J Nucl Med; 2008 Feb; 49(2):186-94. PubMed ID: 18199618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors.
    Troost EG; Bussink J; Hoffmann AL; Boerman OC; Oyen WJ; Kaanders JH
    J Nucl Med; 2010 Jun; 51(6):866-74. PubMed ID: 20484426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
    Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
    Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular imaging: what can be used today.
    Jager PL; de Korte MA; Lub-de Hooge MN; van Waarde A; Koopmans KP; Perik PJ; de Vries EG
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S27-32. PubMed ID: 16361133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT imaging in cancer: current applications and future directions.
    Farwell MD; Pryma DA; Mankoff DA
    Cancer; 2014 Nov; 120(22):3433-45. PubMed ID: 24947987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing the use of PET with selective internal radiation therapy.
    Flamen P
    Future Oncol; 2014 Nov; 10(15 Suppl):73-5. PubMed ID: 25478773
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in research on biological target volume and conformal intensity-modulated radiotherapy].
    Yu JM; Chen SQ
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):801-3. PubMed ID: 17415998
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetic analysis of 18F-FLT PET in lung tumors.
    Bading JR
    J Nucl Med; 2012 Mar; 53(3):506; author reply 506-507. PubMed ID: 22294484
    [No Abstract]   [Full Text] [Related]  

  • 16. PET imaging with 18F-FLT and thymidine analogs: promise and pitfalls.
    Shields AF
    J Nucl Med; 2003 Sep; 44(9):1432-4. PubMed ID: 12960188
    [No Abstract]   [Full Text] [Related]  

  • 17. A digital revolution in radiosynthesis.
    Reichert DE
    J Nucl Med; 2014 Feb; 55(2):181-2. PubMed ID: 24365652
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring tumor response to therapy with 18F-FLT PET.
    Weber WA
    J Nucl Med; 2010 Jun; 51(6):841-4. PubMed ID: 20484418
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter from the Editors: low-sensitivity FDG-PET studies.
    Freeman LM; Blaufox MD
    Semin Nucl Med; 2012 Jul; 42(4):219-20. PubMed ID: 22681670
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of therapy response in malignant tumours with 18F-fluorothymidine.
    Kumar R
    Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1334-8. PubMed ID: 17479261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.